Cargando…
PO-1453 Covid-19 pandemic adapted radiotherapy guidelines: are they really followed?
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ireland Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629149/ http://dx.doi.org/10.1016/S0167-8140(21)07904-4 |
_version_ | 1784607146083614720 |
---|---|
author | Galofaro, E. Malizia, C. Ammendolia, I. Galuppi, A. Guido, A. Ntreta, M. Siepe, G. Tolento, G. Veraldi, A. Scirocco, E. Arcelli, A. Buwenge, M. Ferioli, M. Zamagni, A. Strigari, L. Cammelli, S. Morganti, A.G. |
author_facet | Galofaro, E. Malizia, C. Ammendolia, I. Galuppi, A. Guido, A. Ntreta, M. Siepe, G. Tolento, G. Veraldi, A. Scirocco, E. Arcelli, A. Buwenge, M. Ferioli, M. Zamagni, A. Strigari, L. Cammelli, S. Morganti, A.G. |
author_sort | Galofaro, E. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8629149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ireland Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86291492021-11-30 PO-1453 Covid-19 pandemic adapted radiotherapy guidelines: are they really followed? Galofaro, E. Malizia, C. Ammendolia, I. Galuppi, A. Guido, A. Ntreta, M. Siepe, G. Tolento, G. Veraldi, A. Scirocco, E. Arcelli, A. Buwenge, M. Ferioli, M. Zamagni, A. Strigari, L. Cammelli, S. Morganti, A.G. Radiother Oncol Digital Poster: Health services research/health economics Elsevier Ireland Ltd. 2021-08 2021-09-28 /pmc/articles/PMC8629149/ http://dx.doi.org/10.1016/S0167-8140(21)07904-4 Text en Copyright © 2021 Elsevier Ireland Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Digital Poster: Health services research/health economics Galofaro, E. Malizia, C. Ammendolia, I. Galuppi, A. Guido, A. Ntreta, M. Siepe, G. Tolento, G. Veraldi, A. Scirocco, E. Arcelli, A. Buwenge, M. Ferioli, M. Zamagni, A. Strigari, L. Cammelli, S. Morganti, A.G. PO-1453 Covid-19 pandemic adapted radiotherapy guidelines: are they really followed? |
title | PO-1453 Covid-19 pandemic adapted radiotherapy guidelines: are they really followed? |
title_full | PO-1453 Covid-19 pandemic adapted radiotherapy guidelines: are they really followed? |
title_fullStr | PO-1453 Covid-19 pandemic adapted radiotherapy guidelines: are they really followed? |
title_full_unstemmed | PO-1453 Covid-19 pandemic adapted radiotherapy guidelines: are they really followed? |
title_short | PO-1453 Covid-19 pandemic adapted radiotherapy guidelines: are they really followed? |
title_sort | po-1453 covid-19 pandemic adapted radiotherapy guidelines: are they really followed? |
topic | Digital Poster: Health services research/health economics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629149/ http://dx.doi.org/10.1016/S0167-8140(21)07904-4 |
work_keys_str_mv | AT galofaroe po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT maliziac po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT ammendoliai po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT galuppia po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT guidoa po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT ntretam po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT siepeg po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT tolentog po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT veraldia po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT sciroccoe po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT arcellia po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT buwengem po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT feriolim po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT zamagnia po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT strigaril po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT cammellis po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed AT morgantiag po1453covid19pandemicadaptedradiotherapyguidelinesaretheyreallyfollowed |